1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Evaluation of insulin degludec as baseline insulin therapy in children and adolescents with type 1 diabetes
- Contribution to journal › Article
- 2020
-
Mark
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective
- Contribution to journal › Article